Hostname: page-component-7c8c6479df-5xszh Total loading time: 0 Render date: 2024-03-28T08:49:30.998Z Has data issue: false hasContentIssue false

“… and a small dose of an antidepressant might help”

Published online by Cambridge University Press:  29 January 2018

P. K. Bridges*
Affiliation:
Guy's Hospital Medical School, London and Geoffrey Knight Psychosurgical Unit, Brook General Hospital, Shooters Hill Road, London SE18 4LW

Extract

My association with the psychosurgical unit now carrying out over 80 per cent of these operations in Britain affords an unusual opportunity to assess the management of treatment-resistant affective disorders by a large number of psychiatrists from various parts of the country. The psychiatrists likely to refer patients for psychosurgery would be expected to be those more inclined to use psychotropic medication and physical treatments in general. Nonetheless, our experience is unequivocally of a widespread under-use of antidepressants. Most referral letters state that ‘… just about every antidepressant has been tried …’, but it is rare for the maximum dose of each drug used to be quoted. The letters suggest that with resistant illnesses the prescription of a series of drugs one after another at the usual doses is the therapeutic strategy, rather than giving one drug only in progressively increasing amounts to the limit of tolerance. Of course, the doses recommended by drug companies are understandably cautious and sometimes excessively so. For example, MIMS (November 1982) gives for “Anafranil” (Geigy); “More severe cases, 75 mg daily or more if necessary” and for “Surmontil” (M & B) “50–75 mg as single dose”.

Type
Point of View
Copyright
Copyright © 1983 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bridges, P. K. (1976) Depression by any other name … Postgraduate Medical Journal, 52, 130–5.CrossRefGoogle ScholarPubMed
Dawling, S. (1982) Monitoring of tricyclic antidepressant therapy. Clinical Biochemistry, 15, 5661.CrossRefGoogle ScholarPubMed
Gold, M. S. & Pottash, A. C. (1981) Depression: Diagnosis and treatment with tricyclic antidepressants. Postgraduate Medicine, 69, 104–17.CrossRefGoogle ScholarPubMed
Keller, M. G., Klerman, G. L. Lavori, P. W., Fawcett, J. A., Coryell, W. & Endicott, J. (1982) Treatment received by depressed patients'. Journal of the American Medical Association, 248, 1848–55.Google Scholar
Montgomery, S. A. (1980) Measurements of serum drug levels in the assessment of antidepressants. British Journal of Clinical Pharmacology, 10, 411–16.CrossRefGoogle ScholarPubMed
Uhlenhuth, E. H. (1982) Depressives, doctors, and antidepressants. Journal of the American Medical Association. 248, 1879–80.Google ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.